Joe Weisenthal’s Post

View profile for Joe Weisenthal, graphic
Joe Weisenthal Joe Weisenthal is an Influencer

Editor at Bloomberg

Everyone knows the GLP-1 drugs, like Ozempic, are coming for the food industry. So we talked to flavor expert, and food industry consultant Barb Stuckey about what the big players will do in response. What are the new flavors, new food concepts, and new portion sizes that will win back users of these drugs? Fascinating conversation. https://lnkd.in/ezm9NYrf

This Is How the Food Industry Is Preparing for a Post-Ozempic World

This Is How the Food Industry Is Preparing for a Post-Ozempic World

bloomberg.com

Jessica Kesack

Relationship Banker at Truist Bank

6mo

These drugs are not affordable enough to the majority of people with the huge rise of inflation. Who can afford ozempic and like drugs if not able to be prescribed for diabetes only. Ozempic is for the rich and not the majority

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics